Notice of quarterly dividend

RNS Number : 2802B

The MedicX Fund Limited

15 February 2011

 



For immediate release                                                                                                 15 February 2011

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Notice of quarterly dividend

As announced on 2 February 2011, the Directors have approved a quarterly dividend of 1.375p per ordinary share in respect of the period 1 October 2010 to 31 December 2010.  The dividend will be paid on 31 March 2011 to ordinary shareholders on the register as at close of business 18 February 2011 (the "Record Date").  The corresponding ex-dividend date will be 16 February 2011.  The Directors expect, subject to unforeseen circumstances, to pay dividends totalling 5.5p per Ordinary Share in respect of the financial year ending 30 September 2011.  

The Company is offering qualifying shareholders the opportunity to take new ordinary shares in the Company, credited as fully paid, in lieu of the cash dividend to be paid on 31 March 2011, by participating in a Scrip Dividend Scheme (the "Scheme") previously put in place by the Company on 5 May 2010.    

The option to participate will be available to shareholders until 10 March 2011 (the "election date").  For further information on the Scheme, together with a copy of the Scheme Document (containing the terms and conditions of the Scheme) and relevant mandate forms, please refer to the Scrip Dividend portal on the Company's website.

End

For further information please contact:

MedicX Fund                                                                  [phone]

David Staples, Chairman

MedicX Group                                                                [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Buchanan Communications                                              [phone]

Charles Ryland/Suzanne Brocks

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 57 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 30 people operating across the UK.  

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) are incorporated into, or forms part of, this announcement.

 

END

 

 

DIVDMGMZDKRGMZM